ABIC Score for Alcoholic Hepatitis

The ABIC score stratifies short‑term mortality risk in alcoholic hepatitis using age, bilirubin, INR, and creatinine 1.

mg/dL
mg/dL
yrs

适用指征

Used to stratify short‑term mortality risk in alcoholic hepatitis and guide prognostic counseling, not treatment decisions. Identifies low (<6.71), intermediate, and high (>9.0) 90‑day mortality risk, validated in cohorts predicting survival at 90 days and 1 year 1 [Level I evidence]. High‑risk patients may warrant early transplant evaluation or combined static/dynamic scoring (e.g., ABIC + Lille) to refine prognosis 2 [Level II evidence].

洞见与注意事项

Start by estimating short‑term mortality risk: ABIC <6.71 = low risk; 6.71–9 = intermediate; >9 = high risk (derivation/validation cohorts, N=183; 90‑day AUC 0.82) 1 [Level II evidence].

  • Underestimates benefit threshold for steroids; not validated for treatment decisions and limited outside Spain (AASLD guidance) 2 [Level I evidence].
  • Identifies prognosis only; accuracy improves when combined with Lille at day‑7 (STOPAH, N=1068) 3 [Level I evidence].